Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome

Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome

Files

326 Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlate.pdf(2.46 MB)

Date

2017

Authors

Macanas Pirard, Patricia

Broekhuizen, Richard

González, Alfonso

Oyanadel, Claudia

Ernst Diaz, Daniel Matias

García Cañete, Patricia

Montecinos Acuña, Viviana

Court G., Felipe

Ocqueteau Tachini, Mauricio

Ramírez Villanueva, Pablo Antonio

URI

https://doi.org/10.18632/oncotarget.14981
https://repositorio.uc.cl/handle/11534/30251

Collections

Artículos de revistas